The Times Australia

The Times World News
The Times

Daily aspirin doesn't prevent strokes in older, healthy people after all

  • Written by Nial Wheate, Associate Professor of the Sydney Pharmacy School, University of Sydney
Daily aspirin doesn't prevent strokes in older, healthy people after all

The daily use of low dose aspirin[1] has been a mainstay of preventing strokes for decades. While there has always been a risk of bleeding associated with aspirin use, the benefits were thought to outweigh the risk.

Now new research[2] led by Monash University has shown daily, low-dose aspirin doesn’t prevent strokes in relatively healthy people aged over 70. And it increases their risk of bleeding on the brain after falls or other injuries.

But if you’re taking aspirin, it doesn’t mean you should abruptly stop. It may still have a role to play in treating people at high risk of stroke. Or, after talking to your doctor, there might be better options available.

Read more: Hippocrates and willow bark? What you know about the history of aspirin is probably wrong[3]

Why has aspirin been used to prevent strokes?

Aspirin is an anti-platelet medicine, which is commonly known as a blood-thinner. Platelets[4] are the component of blood primarily responsible for its clotting action. They are what stop you from continuously bleeding any time you have a cut or scrape on your skin.

A stroke[5] is when oxygen can’t get into the brain because of a burst or blocked blood vessel. A blockage can occur when platelets in the bloodstream form a clot and it gets stuck in the artery.

Aspirin tablets
Aspirin is a blood-thinner. Shutterstock[6]

Because aspirin acts on platelets, it can help prevent the clots that can lead to a stroke.

But because aspirin acts on platelets, it can also increase the risk of unwanted bleeding[7], usually in the stomach. It can also increase your risk of bleeding more when you have another injury, like hitting your head.

Aspirin isn’t just used for the prevention of strokes. It is also the first aid treatment for someone undergoing a heart attack[8].

Findings of the Monash trial

New research from Australia and the United States[9] reports results from the Aspirin in Reducing Events in the Elderly (ASPREE) trial.

The researchers examined the protective use of daily low-dose aspirin (100 mg) in nearly 2,000 people who were aged 70 years and older and had no history of heart disease or stroke and whose blood pressure and cholesterol were well managed.

When compared with placebo, aspirin didn’t reduce or increase the risk of stroke. Of the participants who took the aspirin, 195 or 4.6% had a stroke. Of those who took the placebo, 203 people or 4.7% had a stroke.

But it did statistically increase the rate of non-stroke bleeding in the participants’ brains, for example when they injured their head. Those on aspirin showed a rate of bleeding in the brain of 1.1% (108 participants) compared with 0.8% (79 people) for those on placebo. This is a relatively, low but serious, risk.

Read more: Daily low-dose aspirin doesn't reduce heart-attack risk in healthy people[10]

These findings are not entirely new. Research[11] published five years ago based on the same ASPREE trial showed a similar result: a higher rate of bleeding among those taking low-dose aspirin compared with placebo.

However as the study authors note, aspirin continues to be widely used for the prevention of stroke.

What are the study’s limitations?

The researchers examined aspirin in mostly people of white European heritage.

So we don’t know whether the results are translatable to people with different ethnic backgrounds. Genetics and ethnicity[12] can significantly impact the efficacy and safety of some drugs.

The clinical trial only included people who were not significantly at risk of a stroke, and had no history of heart disease.

Younger age groups were not studied either, so we cannot make any conclusions about their use of low dose aspirin to prevent stroke.

It’s also possible the potential benefits and risks are different for those who have underlying heart problems or who have previously had a stroke and are therefore at higher risk of another stroke.

Emergency department entrance
People who have previously had a stroke are at higher risk of another stroke. Shutterstock[13]

I’m taking aspirin, what should I do?

If you’re taking daily low-dose aspirin and are concerned by the results of the study, it’s important you don’t just stop taking your medicine. Speak to your doctor or pharmacist.

For people who are at high risk of having a stroke, or have previously had one, low-dose aspirin may remain their treatment of choice despite the slight bleeding risk.

If you’re at high risk of bleeding, for example because of falls and other accidents due to advanced age, frailty, or another underlying condition, your doctor may be able to reduce the amount of aspirin you take by adding in dipyridamole[14] or prescribing a different medicine completely, such as clopidogrel[15].

Read more: How do painkillers actually kill pain? From ibuprofen to fentanyl, it's about meeting the pain where it's at[16]

References

  1. ^ low dose aspirin (www.nps.org.au)
  2. ^ new research (dx.doi.org)
  3. ^ Hippocrates and willow bark? What you know about the history of aspirin is probably wrong (theconversation.com)
  4. ^ Platelets (www.lifeblood.com.au)
  5. ^ stroke (strokefoundation.org.au)
  6. ^ Shutterstock (www.shutterstock.com)
  7. ^ unwanted bleeding (www.mayoclinic.org)
  8. ^ heart attack (www.nps.org.au)
  9. ^ research from Australia and the United States (dx.doi.org)
  10. ^ Daily low-dose aspirin doesn't reduce heart-attack risk in healthy people (theconversation.com)
  11. ^ Research (www.nejm.org)
  12. ^ Genetics and ethnicity (www.ncbi.nlm.nih.gov)
  13. ^ Shutterstock (www.shutterstock.com)
  14. ^ dipyridamole (www.nps.org.au)
  15. ^ clopidogrel (www.nps.org.au)
  16. ^ How do painkillers actually kill pain? From ibuprofen to fentanyl, it's about meeting the pain where it's at (theconversation.com)

Read more https://theconversation.com/daily-aspirin-doesnt-prevent-strokes-in-older-healthy-people-after-all-210388

‘Dark tourism’ is attracting visitors to war zones and sites of atrocities in Israel and Ukraine. Why?

There is a disturbing trend of people travelling to the sadder places of the world: sites of milit...

Times Lifestyle

The Jewish International Film Festival

JEWISH INTERNATIONAL FILM FESTIVAL BRINGS GLOBAL STORIES TO AUSTRALIAN SCREENS 2024 JIFF Program Announced The Jewish...

Warning to Grey Nomads - Pop Top Caravan Hidden Risks

To pop or not to pop… that is the question. Hybrid pop top caravans are a popular choice for many caravanners, but ar...

How to Ensure You Don’t Miss Out on a Ticket for the Next Huge Ev…

It can be a moment of huge excitement when a concert or huge event is announced to be coming to a nearby venue. There are l...

Times Magazine

The Symbology Of Birthstones

Way back in the Middle Ages, the healers and wise men of the time thought that all gemstones held supernatural powers, a belief that continues on to this very day! The tradition still fascinates us, so let's examine the birthstones and the gift the...

The Science Behind Neodymium Magnets: How They Work and Why They’re So Powerful

In the world of magnets, neodymium magnets are the rock stars. Despite their small size, they are the big hitters. The power and performance of neodymium magnets make them essential in everything from earbuds to electric vehicles. But what exactly ...

The Ethical Considerations of AI Chatbots: Balancing Innovation with Responsibility

The rise of AI chatbots has dramatically transformed how businesses interact with customers. These intelligent tools can handle inquiries, provide support, and even personalize user experiences. However, with this innovation comes a host of ethical c...